Company: CHY
Filing Date: 2025-02-24
Form Type: 424B5
Source: 0001104659-25-016491
Chunk: 4

Company: CALAMOS CONVERTIBLE & HIGH INCOME FUND
Filing Date: 2025-02-24
Form: 424B5
Chunk 4
---
 than debt representing financial leverage). “Net assets” does not include any assets attributable to any leverage that may be outstanding or other debt representing financial leverage. See “Management of the Fund” on page 60 of the accompanying prospectus. The principal business address of the Adviser is 2020 Calamos Court, Naperville, Illinois 60563. The Offering The Fund has entered into a distribution agreement dated February 24, 2025 (the “Distribution Agreement”) with Foreside Fund Services, LLC (the “Distributor”) relating to the common shares offered by this prospectus supplement and the accompanying prospectus. The Distributor has entered into a sub-placement agent agreement dated February 24, 2025 (the "Sub-Placement Agent Agreement") with UBS Securities LLC (the "Sub-Placement Agent"), relating to the Fund's common shares offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sub-Placement Agent Agreement, we may offer and sell up to 17,140,125 of our common shares, no par value per share, from time to time through the Sub-Placement Agent, as the sub-placement agent for the offer and sale of the common shares. Our common shares are listed on the Nasdaq Global Select Market (“Nasdaq”) under the symbol “CHY.” As of January 31, 2025, the last reported sale price for our common shares was $11.42. Sales of our common shares, if any, under this prospectus supplement and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be “at the market” as defined in Rule 415 under the 1933 Act, including sales made directly on the Nasdaq or sales made to or through a market maker other than on an exchange. Our common shares may not be sold through agents, underwriters or dealers without delivery or deemed delivery of a prospectus and a prospectus supplement describing the method and terms of the offering of our securities. Under the 1940 Act, the Fund may not sell any common shares at a price below the current net asset value of such common shares, exclusive of any distributing commission or discount (the “Minimum Price”). SUP-1 Use of Proceeds Unless otherwise specified in this prospectus supplement, we currently intend to use the net proceeds from the sale of our common shares in this offering primarily to invest in accordance with our investment objective and policies (as described under “Investment Objective and Principal Investment Strategies,” beginning